-
-
-
-
-
-
News
-
-
Contact UsThe company focuses on the research, development, production, and sales of chemical raw materials and their formulations. All products have passed national GMP certification, and core products have successively passed official pharmaceutical regulatory certifications from multiple countries, including the EU EDQM, US FDA, Japanese PMDA, and South Korean MFDS. Following its successful listing on the Shenzhen Stock Exchange's ChiNext board on April 4, 2023, Keyuan Pharmaceutical has entered a phase of rapid development driven by both digital intelligence and capital, with its business spanning dozens of countries and regions worldwide.
Historical Evolution
December 2012
Achieved a profit exceeding 10 million yuan for the first time in a year.
June 2005
The active pharmaceutical ingredient, Glezetide, has received the company's first international certification - the Korean MFDS certification, opening up the company's path to international development.
December 2004
Shandong Keyuan Pharmaceutical Co., Ltd. was established. It obtained 15 raw material drug product GMP certificates at once.
Address: No. 26, Keyuan Street, Shanghe County, Jinan City, Shandong Province
Free Service Hotline